Satellos Bioscience Inc. (MSCL.TO)

0.5900 0.0000 (0.00%) At close: 03:59PM EDT

Satellos Bioscience Inc.

Royal Bank Plaza
Suite 2800 South Tower 200 Bay Street
Toronto, ON M5J 2J1
Canada

https://satellos.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Description

Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of Duchenne. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Corporate governance

Satellos Bioscience Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.